Premium
Role of the clinical pharmacist in improving the appropriateness of venous thromboembolism prophylaxis in hospitalised patients in Jordan
Author(s) -
Gharaibeh Lubna,
Younes Nidal,
AlbsoulYounes Abla
Publication year - 2017
Publication title -
journal of pharmacy practice and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.222
H-Index - 22
eISSN - 2055-2335
pISSN - 1445-937X
DOI - 10.1002/jppr.1230
Subject(s) - medicine , concordance , pharmacist , venous thromboembolism , clinical pharmacy , intensive care medicine , emergency medicine , family medicine , thrombosis , pharmacy
Background Venous thromboembolism ( VTE ) is one of the most important preventable causes of death in hospitalised patients. The role of the clinical pharmacist in Jordan is still at its beginnings in this field; this study explored the contribution of the clinical pharmacist to improving the frequency of appropriate VTE prophylaxis. Aim To evaluate the role of the clinical pharmacist in improving appropriate VTE prophylaxis in a tertiary hospital. Methods This study with a single‐group pretest‐post test design. Recommendations of the clinical pharmacist concerning VTE prophylaxis for a group of hospitalised patients with odd ID numbers were provided to physicians. The main outcome measure was the appropriateness of VTE prophylaxis; therapy was defined as appropriate when it was fully concordant with the American College of Chest Physicians ( ACCP ) guidelines. Appropriateness of VTE prophylaxis was measured before and after the provision of recommendations. Results The extent of concordance with the ACCP guidelines increased from 78.9% to 87.8%, with a statistically significant increase of 8.9% (p < 0.001). Conclusion Employment of a clinical pharmacist coincided with an improvement in the rate of appropriate VTE prophylaxis.